Catestatin decreases macrophage function in two mouse models of experimental colitis
Authors:
- 1 June 2014
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 89 (3) , 386-398
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The N-Terminal Fragment of Chromogranin A, Vasostatin-1 Protects Mice From Acute or Chronic Colitis Upon Oral AdministrationDigestive Diseases and Sciences, 2012
- The neuropeptide catestatin promotes vascular smooth muscle cell proliferation through the Ca2+–calcineurin–NFAT signaling pathwayBiochemical and Biophysical Research Communications, 2011
- Catestatin: A multifunctional peptide from chromogranin ARegulatory Peptides, 2010
- Two Chromogranin A-Derived Peptides Induce Calcium Entry in Human Neutrophils by Calmodulin-Regulated Calcium Independent Phospholipase A2PLOS ONE, 2009
- Serum concentration of chromogranin A at admission: An early biomarker of severity in critically ill patientsAnnals of Medicine, 2009
- Cell-penetrating peptides and antimicrobial peptides: how different are they?Biochemical Journal, 2006
- Tumour necrosis factor α blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitisGut, 2006
- The effect of a chromogranin A-derived peptide (CgA4-16) in the writhing nociceptive response induced by acetic acid in ratsLife Sciences, 2004
- Catestatin (Chromogranin A344‐358) Stimulates Release of Histamine from Rat Pleural and Peritoneal Mast CellsAnnals of the New York Academy of Sciences, 2002
- Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel diseaseInflammation Research, 1988